David Heimbrook
Impact in
- Oncology top 1%
- Cancer-related Molecular Pathways
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways
- Melanoma and MAPK Pathways
- Epigenetics and DNA Methylation
- DNA Repair Mechanisms
Papers in
-
- Ubiquitin and proteasome pathways 7
- Melanoma and MAPK Pathways 7
- PI3K/AKT/mTOR signaling in cancer 7
- Oncology 33
- Cancer-related Molecular Pathways 18
- Co-authors
- Christian Tovar (10 shared papers)Lyubomir T. Vassilev (4 shared papers)Allen Oliff (23 shared papers)Kathryn Packman (18 shared papers)Xiaolan Zhao (3 shared papers)Stephen G. Sligar (6 shared papers)Kenneth Kolinsky (17 shared papers)Brian Higgins (10 shared papers)
- Journals
- Journal of Biological Chemistry (10 papers)Molecular and Cellular Biology (8 papers)Cancer Research (8 papers)Molecular Cancer Therapeutics (4 papers)Proceedings of the National Academy of Sciences (4 papers)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
David Heimbrook
70 papers receiving 4.7k citations
David Heimbrook's Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 2.2k
- Molecular Biology 3.0k
- Cell Biology 617
- Biotechnology 293
- Cancer Research 455
Countries citing papers authored by David Heimbrook
This map shows the geographic impact of David Heimbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Heimbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Heimbrook more than expected).
Fields of papers citing papers by David Heimbrook
This network shows the impact of papers produced by David Heimbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Heimbrook. The network helps show where David Heimbrook may publish in the future.
Co-authors
The 25 scholars most cited alongside David Heimbrook, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1 Hit paper breakdown → | 2006 | 638 |
| 2 | Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy Hit paper breakdown → | 2006 | 570 |
| 3 | 2010 | 322 | |
| 4 | 2004 | 200 | |
| 5 | 1993 | 184 | |
| 6 | 2011 | 180 | |
| 7 | 1982 | 175 | |
| 8 | Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1. | 1984 | 167 |
| 9 | 2009 | 166 | |
| 10 | 2005 | 161 | |
| 11 | 1987 | 142 | |
| 12 | 1993 | 114 | |
| 13 | 1993 | 109 | |
| 14 | 2006 | 92 | |
| 15 | 1994 | 77 | |
| 16 | 1990 | 76 | |
| 17 | 1995 | 69 | |
| 18 | 2011 | 66 | |
| 19 | 1990 | 65 | |
| 20 | 2008 | 63 |
About David Heimbrook
David Heimbrook is a scholar working on Molecular Biology, Oncology, Genetics, Epidemiology and Immunology, having authored 70 papers that have together received 4.9k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (18 papers), Virus-based gene therapy research (11 papers), Cervical Cancer and HPV Research (8 papers), Ubiquitin and proteasome pathways (7 papers), Melanoma and MAPK Pathways (7 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), Microtubule and mitosis dynamics (6 papers) and Toxin Mechanisms and Immunotoxins (6 papers). The work is most often cited by research in Oncology (2.2k citations), Molecular Biology (3.0k citations), Cell Biology (617 citations), Biotechnology (293 citations) and Cancer Research (455 citations). David Heimbrook has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Christian Tovar, Lyubomir T. Vassilev, Allen Oliff, Kathryn Packman, Xiaolan Zhao, Stephen G. Sligar, Kenneth Kolinsky, Brian Higgins, Binh Thanh Vu and Dejan Knezevic. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology, Cancer Research, Molecular Cancer Therapeutics and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.